SciELO - Scientific Electronic Library Online

 
vol.64 número2Neumonía por Legionella pneumophila: Experiencia en un Hospital Universitario de Buenos AiresEvaluación de un programa de educación de tratamiento intensivo en adolescentes con diabetes tipo 1: Seguimiento por dos años índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Bookmark


Medicina (Buenos Aires)

versión On-line ISSN 1669-9106

Resumen

NEGRI, Armando Luis; NEGROTTI, Teresa; ALONSO, Guillermo  y  PASQUALINI, Titania. Different forms of clinical presentation of an autosomal dominant hypophosphatemic rickets caused by a FGF 23 mutation in one family. Medicina (B. Aires) [online]. 2004, vol.64, n.2, pp. 103-106. ISSN 1669-9106.

In this report we describe different forms of clinical presentation of an autosomal dominant hypophosphatemic rickets (ADHR) in 4 members of the same family as well as the treatment used in these patients and their response to it. Patient N° 1: a 60 year old female who consulted for bone pain. Bone densitometry showed osteoporosis. Laboratory assays showed hypophosphatemia with low renal phosphate threshold, high total alkaline phosphatase, normal intact PTH and normal serum calcium. With neutral phosphate and calcitriol, the biochemical parameters normalized and bone densitometry improved significantly in less than a year. Patient N° 2: her grand daughter consulted at 1 year and  8 months of age for growth retardation (height at percentile 3) and genu varum. Laboratory assays showed low serum phosphate and high total alkaline phosphatase; thickening and irregular epiphyseal borders of the wrists were observed radiologically. She began treatment with calcitriol and phosphorus with normalization of laboratory parameters and  increase in growth (height increasing to percentile 50 after 20 months of therapy). Patient N° 3: mother of patient N° 2, she had no clinical manifestations and normal densitometry but presented low serum phosphate (1.9 mg/dl) that normalized with neutral phosphate therapy. Patient N° 4: he was the youngest son of  Patient N° 1, who had had hypophosphatemic rickets, by age 5; his serum phosphate normalized without treatment. At age 29, he presented normal serum phosphate and bone densitometry. Genomic DNA analysis performed in patient N° 3, showed missense mutation with substitution of arginine at position 179 for glutamine. The family was catalogued as having autosomal dominant hypophosphatemic rickets/osteomalacia.

Palabras llave : Autosomal dominant hypophosphatemic rickets; Fibroblast growth factor 23; Renal phosphate wasting; Hereditary hypophosphatemic rickets.

        · resumen en Español     · texto en Español     · pdf en Español